HOW YOU CAN HELP
We believe in combining scientific rigour and local commitment. Every donation helps to finance a study,
create a medicinal plant garden, train a local team, open a La Maison de l’Artemisia centre or finance
production tools.
€100 = Provide 10g of Artemisia afra seed
€500 = Cover one-month salary of African agronomist
€2000 = Fund training session in Africa
DONATIONS
Secure payment on Hello Asso: www.donnerenligne.fr/maison-artemisia/faire-un-don
IFI (wealth tax France) : www.fondationcaritasfrance.org/fondations/fondation-terra-artemisia
Docteur Lucile Cornet-Vernet
lcv@maison-artemisia.org
Heartfelt thanks for
your support
Bibliography
In 1970, in China, laboratories in the provinces of Shandong and Yunnan
carried out convincing clinical trials with Artemisia annua herbal tea and
capsules. 30 P.vivax cases took 3g of Artemisia annua leaf and stem pow-
der for 6 days and had excellent therapeutic results, better than the group
treated with chloroquine.
Zhang, JF. A detailed chronological record of Project 523 and the discovery
and development of qinghaosu (artemisinin). Vol. 193. Yangcheng Evening
News Publishing Company; China: 2005
In 2000, in DRC, Mueller et al. treated 53 patients infected with
Plasmodium falciparum using two types of preparation: herbal tea and
decoction. The dosage was 5 g of dry Artemisia annua herbal tea/ liter,
1L/ day
for 5 days. The cure rate was 100% with the infusion and 92% with the
decoction.
Mueller et al: The potential of Artemisia annua L. as a locally
produced remedy for malaria in the tropics : agricultural, chemical and
clinical aspects / Journal of Ethnopharmacology 73 (2000) 487–493
In 2010, Ethiopia, Gebeyaw et al. conducted a study of 73 patients treated
for simple malaria with 1L of Artemisia annua at 5g / L per day for 7 days.
95.5% of patients were cured without any side effects being observed.
Gebeyaw Tiruneh et al : Use of the plant Artemisia annua as a natural an-
ti-malarial herb in Arbaminch town. Ethiop. J. Health Biomed Sci., 2010. Vol.2,
No.2
In 2011 in Uganda, P Ogwang demonstrated the preventive effect of
Artemisia annua on malaria on 132 adults who took 1 cup of herbal tea
once a week and reduced their risk of malaria by 55%.
Patrick E. Ogwang et al : Use of Artemisia annua L. Infusion for Malaria
Prevention : Mode of Action and Benefits in a Ugandan Community / British
Journal of Pharmaceutical Research 1(4): 124-132, 2011
WWW.MAISON-ARTEMISIA.ORG
€5000 = Finance medicinal plant garden
€20,000 = Fund new La Maison de l’Artemisia centre
€40,000-€80,000 = Finance clinical trial
In 2012, in Cameroon, Chougouo-Kengne et al. published the first study
comparing the effectiveness of Artemisia annua herbal tea with that of
Artesunate alone or in combination with Amodiaquine in 73 patients with
simple Plasmodium falciparum malaria. The dosage was 5g of dry leaves
per liter of boiling water to be taken during the day for 5 or 7 days. Increa-
sing the duration of treatment improved the therapeutic effectiveness of
the herbal tea, from 71.3% to 100% with no side effects.
Rosine Chougouo-Kengne et al : Etude comparative de l’efficacité
thérapeutique de l’Artesunate seul ou en association avec l’amodiaquine et
de la tisane d’Artemisia annua cultivée à l’ouest de Cameroun / Annales de
Pharmacie, Université de Kinshasa Vol 4, N1, Avril 2012 pp127-148
2013: Publication by Springer on Artemisia annua. Weathers PJ, Reed K,
Hassanali A, Lutgen P, Engeu Chapter 4: Whole plant approaches to therapeu-
tic use of Artemisia annua, L. (Asteraceae). /IN: Artemisia annua. Pharmaco-
logy and Biotechnology. Eds., T Aftab, JFS Ferreira, MMA Khan,
M Naeem Springer, Heidelberg, GDR pp. pending
In 2015 in Benin, Zime-Diawara et al. carried out a clinical study on 108
patients who received 1L of Artemisia annua herbal tea dosed at 12g /
L during 7 days. Parasitaemia was eradicated in 100% of patients after
36 hours with excellent clinical tolerance. Zime-Diawara H. et al. Etude de
l’efficacité et de la tolérance d’une tisane à base d’Artemisia annua L. (Aste-
raceae) cultivée au Bénin pour la prise en charge du paludisme simple. Int. J.
Biol. Chem. Sci. 9(2): 692-702, 2015
In April 2017, Pamela Weathers and her team cured 18 cases of severe
ACT-resistant malaria in 5 days in DR Congo. Patients took a 0.5g dose of
dried Artemisia annua leaves twice a day for 5 days.
Nsengiyumva Bati Daddy, et al. : Artemisia annua dried leaf tablets treated ma-
laria resistant to ACT and i.v. artesunate: Case reports- Phytomedicine, Volume
32, 15 August 2017, Pages 37-40
Together we shall
defeat malaria!
OUR MISSION
To prove the medical effectiveness of selected medicinal plants and
develop their use in Africa for the benefit of the most deprived.

The spectacular recovery of her friend,
Alexandre Poussin, in Ethiopia, from
neuro-malaria with an Artemisia annua
herbal tea incited
Dr. Lucile Cornet-Vernet to seek
scientific evidence of its effectiveness.
This was the beginning of the La
Maison de l’Artemisia adventure.
Since 2013, this non-profit organization
has been constantly striving to
create a global network of doctors,
researchers, agronomists, farmers,
NGOs and volunteers working in
synergy to prove that this plant and
others cure diseases as serious as
malaria, bilharzia, tuberculosis and
Buruli ulcer. La Maison de l’Artemisia
has financed six clinical trials in Africa,
including some to WHO standards,
two of which have been published in
2018/2019 PhytoMedecine medical
review..
La Maison de l’Artemisia has thus
proved that Artemisia annua or
afra herbal teas cure malaria from
Plasmodium falciparum and bilharzia
with no toxicity, no side effects and no
induced resistance.
This is because they contain hundreds
of active ingredients that interact,
and are true polytherapies. Moreover,
they have been used for centuries in
Traditional Medicine in China and
East Africa, without ever inducing
resistance. MALARIA FACTS
By helping to develop the production of
these medicinal plants, La Maison de
l’Artemisia enables local populations 435 000
+in nearly twenty African countries deaths every year
to treat themselves locally, efficiently
and at low cost when one in two drugs
sold in Africa is counterfeit and drug 219 million
resistance is developing. malaria cases in 2015
This approach is in line with the
wishes of the WHO which states in its 3 billion
Traditional Medicine Strategy 2014- people live in malaria-
2023 that “Traditional Medicine, of infected areas
proven quality, safety, and efficacy,
contributes to the goal of ensuring
that all people have access to care”
and “will help health care leaders to
Increased
develop solutions that contribute to a resistance
broader vision of improved health and to conventional
patient autonomy.” medicine
Source : WHO 2017

THE MISSION OF LA MAISON DE L’ARTEMISIA IS TO PROVE

AND PUBLISH SCIENTIFIC MEDICAL EVIDENCE OF THE EFFECTIVENESS OF SELECTED
MEDICINAL PLANTS AND TO ORGANISE A NETWORK OF PRODUCERS AND RESELLERS
UNDER A RECOGNISED QUALITY LABEL.

LA MAISON DE L’ARTEMISIA - 20 RUE PIERRE DEMOURS - 75017 PARIS - FRANCE

CLINICAL STUDIES

La Maison de l’Artemisia has conducted clinical studies to WHO standards to demonstrate the
effectiveness of Artemisia annua and Artemisia afra on malaria, bilharzia, tuberculosis and Buruli
ulcer. To date, few studies of this kind have been conducted because modern medicine is based
primarily on the patenting of active molecules for a given pathology. A medicinal plant is extremely
complex to study, difficult to patent and attracts little investment.

Published studies
2016
Double-blind randomized malaria clinical trial on Public health study in Lubile, DRC :
957 patients:
Impact of preventive use of Artemisia annua herbal tea
Effectiveness of Artemisia annua or afra herbal teas on malaria incidence - May 2018.
compared to ACT combination (Artesunate-Amodiaquine) 300% reduction in malaria incidence in zones covered by
in the treatment of simple malaria with Plasmodium 2016 clinical study.
falciparum in the health zone of Kalima, Maniema, Congo
(DRC). Study produced by:
Lucie Peters 1
Cure rate from the parasite : 1 - ISPED Faculty of Pharmacy, University of Bordeaux, France.
99.5% with Artemisia, 79.5% with ACT.
Phytomedicine, Volume 51, 1 December 2018, Pages 233-240
clinical studies in progress

Double-blind randomized bilharzia clinical trial on Randomised double-blind clinical trial on tuberculosis in
800 patients: 600 patients:
Curative effectiveness of Artemisia afra on pulmonary
Curative effectiveness of Artemisa annua or afra versus tuberculosis.
Prazicantel on schistosomiasis in Maniema, Congo (DRC). Absence of Koch bacilli in sputum after 3 weeks of taking
herbal tea.
Cure rate from the parasite:
90% with Artemisia, 65% with Prazicantel. Clinical trial on combination of Artemisia afra herbal tea
and application of Artemisia afra cream to treat patients
Phytomedicine, Volume 51, 1 December 2018, Pages
233-240
suffering from Buruli ulcer:
Encouraging effects on wound healing.
Study results under compilation.
Studies co-produced by:
Dr Jérôme Munyangi1, Dr Lucile Cornet-Vernet2, Randomised clinical trial of preventive effectiveness of Ar-
temisia annua herbal tea on malaria compared to placebo
Dr Michel Idumbo3, Pr Chen Lu4, Pr Pierre Lutgen5, Pr
in 400 school children, Maniema, DRC.
Christian Perronne6, Drastic reduction of parasitaemia and anaemia with Artemi-
Pr Nadège Ngombe7, Pr Jacques Bianga8, sia afra herbal tea.
Pr Bavon Mupenda9, Pr Paul Lalukala10, Pr Guy Mergeai11,
Pr Dieudonné Mumba12 , Pr Melissa Towler13, Pr Pamela
Weathers14
1 - Faculty of Medicine, University of Kolwesi-Lualaba, Congo DRC.
Interdisciplinary Research Center of the Living, Paris, France.
2 - Association La Maison de l’Artemisia, Paris, France.
3 - Lubile Health Center, Maniema, Congo DRC.
4 - Mathematic department - Worcester Polytechnic Institute, USA.
5 - Association IFVB, Luxembourg.
6 - Department of Infectious Diseases, University Hospital of Garches, Faculty of
Medicine of West Paris region, France.
7 - Faculty of Pharmacy, University of Kinshasa, Congo DRC.
8 - National Program to Combat Malaria, Maniema, Congo DRC.
9 - School of Public Health, University of Kinshasa, Congo DRC.
10 - Ministry of Public Health, Maniema, Congo DRC.
11 - Gembloux Agro-biotech, University of Liège, Belgium.
12 - Faculty of Medicine, University of Kinshasa, Congo DRC.
13/14 - Biology and biotechnology department - Worcester Polytechnic Institute, USA.

LA MAISON DE L’ARTEMISIA - 20 RUE PIERRE DEMOURS - 75017 PARIS - FRANCE

OUR ACTION
Charter
and shared quality label
Sustainable and Responsible
Production
Production without pesticides or GMOs
Responsible Processing
Drying, shredding and packaging under clearly
defined hygiene standards
Fair Income
For farmers, processors and resellers
Fair Price
Affordable sales price to ensure the most
deprived have access to the herbal tea
Sharing knowledge, expertise and
experience within the network
Joint Communication
WWW.MAISON-ARTEMISIA.ORG
Since 2012, we have brought together agronomic
expertise and humanitarian activities to promote the
production of Artemisia species in malaria-affected
countries. Medical, university and health professionals
and community leaders from around the world are
working with us to accelerate the adoption of Artemisia
herbal tea therapy as a recognised cure for malaria,
bilharzia and other tropical diseases.
La Maison de l’Artemisia centres produce, process and
distribute Artemisia.
To ensure the rapid spread of this therapy, the Maison de
l’Artemisia teams offer agronomic and medical training based
on scientific data.
Together, they form a network of over 18 African countries
that support each other and share information through new
technologies, social networks or face-to-face meetings.
We are present in Senegal, Burkina Faso, Mali, Guinea Conakry,
Côte d’Ivoire, Togo, Benin, Gabon, Cameroon, Chad, DR Congo,
Congo Brazza, Burundi, Central African Republic, Niger,
Madagascar, Sierra Leone and Rwanda..
New centres will be opening soon in Cambodia, Vietnam,
Bangladesh, Myanmar, Thailand, Venezuela and Peru.
Ongoing and future projects
Publish our studies and findings in scientific journals
Expand La Maison de l’Artemisia network by rolling
out training courses in countries where we are not yet
established
Continue agronomic research to select seeds adapted to
each biotope and continue medical research, particularly
on the preventive effect of Artemisia species
Identify local partners to organise sales and
distribution channels